When a company acquires another company, the accounting follows a precise sequence: the purchase price is allocated to identifiable assets and liabilities at fair value, and the residual, the amount paid above the fair value of identifiable net assets, is recorded as goodwill.
Goodwill is not an asset in the conventional sense. It does not generate cash independently. It cannot be sold separately. It has no physical form, no contractual basis and no defined useful life. It is the accounting residue of a price that management paid for expected future performance that could not be separately identified, separately measured or separately valued.
That residue can represent genuine economic value: customer relationships, assembled workforce, market position, synergies and growth potential that the acquired business possesses but that accounting standards cannot separately recognise. It can also represent something less flattering: the premium management paid above economic value because of competitive auction dynamics, strategic overconfidence, integration optimism or the simple desire to close the deal.
The balance sheet does not distinguish between these two explanations. It records both at the same value. And it carries that value forward, untouched, until an impairment test says otherwise.
The Impairment Test: Where Judgment Becomes Consequential
Goodwill is tested for impairment annually by comparing the carrying amount of the cash-generating unit to its recoverable amount. If the recoverable amount exceeds the carrying amount, no impairment is required. If it does not, goodwill is written down.
The recoverable amount is calculated as the higher of fair value less costs to sell and value in use. Value in use is typically a discounted cash flow calculation requiring projections of revenue, margins, capital expenditure, working capital and terminal value, discounted at a rate that reflects the risk of the cash flows.
Every input in this calculation is controlled by management. The revenue growth assumption. The margin trajectory. The terminal growth rate. The discount rate. The capital expenditure assumptions. Each is a judgment. And each judgment can be set at a level that produces the desired conclusion.
A management team that needs to avoid an impairment has the technical ability to adjust any of these inputs within the range of “reasonable” assumptions to produce a recoverable amount that exceeds the carrying value. An impairment model can be mathematically precise while being economically wrong, if the inputs are calibrated to the conclusion rather than to the evidence.
The Forensic Approach
In Northrop Management’s forensic and financial reporting practice, goodwill impairment analysis is tested by inverting the model.
Instead of asking “does the model support the current carrying value?”, ask: “What assumptions would trigger an impairment, and how plausible are those assumptions?”
If a 3% reduction in the revenue growth assumption, or a 1% increase in the discount rate, or a 2% reduction in the terminal margin would trigger a material impairment, the goodwill is sitting on the edge of a write-down that management’s chosen assumptions are holding at bay.
The second forensic test: compare management’s impairment model assumptions to the actual performance of the acquired business since acquisition. If management projected 15% revenue growth at the time of acquisition and the business has delivered 8% for three consecutive years, the impairment model should reflect the evidenced growth rate, not the original projection.
A model that uses assumptions contradicted by actual performance is not a valuation. It is a preservation exercise.
Ashish Chaudhary, frames the governance question directly: “Is management forecasting the business, or forecasting the assumptions necessary to avoid an impairment? The balance sheet cannot tell you the difference. The audit committee must.”
Questions for the Boardroom
- For every acquisition with goodwill on our balance sheet, has the acquired business performed at, above or below the projections that supported the original purchase price?
- What change in assumptions (revenue growth, margins, discount rate) would trigger a material goodwill impairment, and how far are we from those trigger points?
- Are the assumptions in our impairment models consistent with the actual performance of the acquired businesses, or do they reflect the original acquisition thesis?
- If an independent party prepared the impairment model using externally observable data rather than management’s internal projections, would the conclusion change?
- What would our reported net worth be if we wrote off all goodwill from acquisitions where post-close performance has fallen below the original thesis?
Closing Implication
Goodwill is either the most valuable asset on the balance sheet or the most misleading. It represents either genuine economic value that the acquisition created, or the accounting preservation of a premium that the market no longer supports.
The board’s role is to determine which. And the tool for making that determination is not the impairment model, which management controls, but the comparison between the model’s assumptions and the business’s actual performance, which reality controls.
